Voloridge Investment Management
AGIO icon

Voloridge Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Voloridge Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187,395
Closed -$6.23M – 1161
2025
Q2 		$6.23M Sell
187,395
-144,248
-43% -$4.37M 0.02% 692
2025
Q1 		$9.72M Buy
331,643
+131,162
+65% +$4.35M 0.04% 573
2024
Q4 		$6.59M Buy
200,481
+4,082
+2% +$192K 0.02% 694
2024
Q3 		$8.73M Sell
196,399
-124,132
-39% -$5.64M 0.03% 625
2024
Q2 		$13.8M Buy
320,531
+277,318
+642% +$10M 0.05% 483
2024
Q1 		$1.26M Buy
+43,213
New +$1.16M ﹤0.01% 941
2022
Q3 		– Sell
-163,784
Closed -$3.63M – 1371
2022
Q2 		$3.63M Sell
163,784
-16,145
-9% -$365K 0.02% 793
2022
Q1 		$5.24M Buy
179,929
+134,850
+299% +$4.12M 0.03% 618
2021
Q4 		$1.48M Buy
45,079
+27,640
+158% +$1.11M 0.01% 1162
2021
Q3 		$805K Buy
+17,439
New +$842K 0.01% 1341
2021
Q1 		– Sell
-15,910
Closed -$689K – 1353
2020
Q4 		$689K Buy
+15,910
New +$629K 0.01% 1069
2020
Q3 		– Sell
-7,384
Closed -$395K – 1221
2020
Q2 		$395K Buy
+7,384
New +$342K ﹤0.01% 1079
2019
Q1 		– Sell
-36,922
Closed -$1.7M – 915
2018
Q4 		$1.7M Buy
+36,922
New +$2.28M 0.08% 213

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Voloridge Investment Management's AGIO Position: Q3 2025 in Review

Voloridge Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 187,395 shares — an estimated $6.23M sold.

Voloridge Investment Management first reported a position in AGIO in Q4 2018 and held it in 13 quarters. The position peaked at $13.8M in Q2 2024. 221 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Voloridge Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 187,395 Agios Pharmaceuticals shares in Q3 2025, an estimated $6.23M.
  • Voloridge Investment Management first reported a position in Agios Pharmaceuticals in Q4 2018 and held it in 13 quarters.
  • Voloridge Investment Management's Agios Pharmaceuticals position peaked at $13.8M in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.